Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AstraZeneca
Company Monitoring Page for AstraZeneca
latest headlines for company on cafepharma
AstraZeneca leaps after smashing first-quarter forecasts
Reuters
Thu, 04/25/24 - 11:42 am
Tags:
AstraZeneca
,
earnings
AstraZeneca’s Lynparza to remain dominant in PARP inhibitors market with $4 billion in sales by 2027
Biopharma Reporter
Thu, 04/25/24 - 11:36 am
Tags:
AstraZeneca
,
PARP inhibitors
,
Merck
,
Lynparza
,
ovarian cancer
AstraZeneca’s Tagrisso maintains momentum in NSCLC with FLAURA2 results
Clinical Trials Arena
Fri, 04/19/24 - 11:26 am
Tags:
AstraZeneca
,
non-small cell lung cancer
,
Tagrisso
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Fierce Biotech
Thu, 04/18/24 - 11:11 am
Tags:
M&A
,
biotech
,
AstraZeneca
,
Merck
,
Gracell
,
Harpoon Therapeutics
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
BioSpace
Fri, 04/12/24 - 11:15 am
Tags:
AstraZeneca
,
Fasenra
,
severe asthma
,
FDA
,
eosinophilic asthma
,
pediatric
Shareholders approve AstraZeneca's 2024 pay proposal for CEO Pascal Soriot despite proxy adviser discontent
Fierce Pharma
Fri, 04/12/24 - 11:01 am
Tags:
AstraZeneca
,
Pascal Soriot
,
Pharma CEOs
,
executive compensation
Leading AstraZeneca investor defends CEO pay ahead of shareholder vote
Fierce Pharma
Wed, 04/10/24 - 05:47 pm
Tags:
AstraZeneca
,
Pascal Soriot
,
Pharma CEOs
,
executive compensation
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
Tags:
oncology
,
M&A
,
AbbVie
,
Immunogen
,
Bristol Myers Squibb
,
Mirati Therapeutics
,
RayzeBio
,
Novartis
,
MorphoSys
,
AstraZeneca
,
Fusion Pharmaceuticals
,
JNJ
,
Ambrx
,
Gracell
FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers
Investing.com
Sun, 04/7/24 - 04:45 pm
Tags:
AstraZeneca
,
Daiichi Sankyo
,
FDA
,
Enhertu
,
solid tumors
AstraZeneca’s Imfinzi tackles another type of lung cancer with latest trial win
Fierce Pharma
Fri, 04/5/24 - 11:28 am
Tags:
AstraZeneca
,
Imfinzi
,
clinical trials
,
limited-stage small cell lung cancer
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
Tags:
biotech
,
M&A
,
IPOs
,
CG Oncology
,
Kyverna Therapeutics
,
Contineum Therapeutics
,
Boundless Bio
,
CymaBay Therapeutics
,
Gilead Sciences
,
MorphoSys
,
Novartis
,
Fusion Pharmaceuticals
,
AstraZeneca
,
Ambryx
,
JNJ
,
Inhibrix
,
Aventis
AZ, Daiichi Sankyo file Dato-DXd for second indication
Pharmaphorum
Tue, 04/2/24 - 11:31 am
Tags:
AstraZeneca
,
Daiichi Sankyo
,
Dato-DXd
,
breast cancer
AstraZeneca CEO's 2024 pay proposal under fire from influential proxy advisers
Fierce Pharma
Mon, 04/1/24 - 11:18 pm
Tags:
AstraZeneca
,
Pascal Soriot
,
Pharma CEOs
,
executive compensation
AstraZeneca Gets FDA Approval in Boost to Rare Disease Franchise
BioSpace
Mon, 04/1/24 - 11:58 am
Tags:
AstraZeneca
,
FDA
,
rare disease
,
danicopan
,
PNH
AstraZeneca CEO ‘deeply humbled’ by award recognizing pandemic efforts
Biopharma Reporter
Thu, 03/28/24 - 11:18 am
Tags:
AstraZeneca
,
Pharma CEOs
,
Pascal Soriot
,
vaccines
,
COVID-19
Brainomix AI shows its worth in AZ pulmonary fibrosis trial
Pharmaphorum
Wed, 03/27/24 - 10:55 am
Tags:
AstraZeneca
,
Brainomix
,
tralokinumab
,
IPF
,
artificial intelligence
Big Pharma CEOs gather in Beijing to show continued interest in China, offer policy advice
Fierce Pharma
Tue, 03/26/24 - 04:26 pm
Tags:
China
,
Pharma CEOs
,
AstraZeneca
,
Bayer
,
Bristol Myers Squibb
,
GSK
,
Novartis
,
Pfizer
,
Takeda
AstraZeneca’s rare disease unit overcomes FDA snub to expand Ultomiris in NMOSD
Fierce Pharma
Mon, 03/25/24 - 10:31 pm
Tags:
AstraZeneca
,
Soliris
,
NMOSD
,
Ultomiris
GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month
Fierce Pharma
Thu, 03/21/24 - 06:37 pm
Tags:
GSK
,
Boehringer Ingelheim
,
AstraZeneca
,
drug pricing
,
COPD
,
asthma
Merck combination treatment for lung cancer fails late-stage study
Reuters
Thu, 03/21/24 - 11:13 am
Tags:
Merck
,
Keytruda
,
Lynparza
,
AstraZeneca
,
non small cell lung cancer
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.